| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 752892 | N-[4-(4-Benzoylamino-pyrrolo[3,2-c]pyridin-1-yl)-phenyl]-4-(4-morpholin-4-yl)-3-trifluoromethylbenzamide | 0.0284045326811618 | 0.1816189 |
| NSC 75520 | Thymidine, .alpha.,.alpha.,.alpha.-trifluoro- (8CI 9CI) | 0.0284045326811618 | 0.13558316 |
| NSC 758845 | Null | 0.0284045326811618 | 0.013281038 |
| NSC 87500 | Solacongestidine | 0.0284045326811618 | 0.043002669 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0286383688883668 | 0.078270366 |
| NSC 149765 | 1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)-, phosphate (1:2) (9CI) | 0.0286383688883668 | 0.091912588 |
| NSC 175493 | Iron, carbonyl(.eta.(5)-2,4-cyclopentadien-1-yl)(dimethylcarbamodithioato-S,S')- | 0.0286383688883668 | 0.25788541 |
| NSC 176328 | Ellipticine, 6-(3-aminopropyl)-, dihydrochloride | 0.0286383688883668 | 0.13856614 |
| NSC 208885 | Null | 0.0286383688883668 | 0.14883892 |
| NSC 21683 | Null | 0.0286383688883668 | 0.19451364 |